$MIRXES-B(_老虎社区_美港股上老虎

$MIRXES-B(02629)$ 3月是结直肠癌宣传月，而就在近期觅瑞结直肠癌产品已完成6000例临床入组，预计明年年中启动商业化。这种“成熟产品稳现金流+新品不断放量”的节奏，挺有看头的。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":541793837334752,"tweetId":"541793837334752","gmtCreate":1773299456089,"gmtModify":1773299458662,"author":{"id":4214972246749820,"idStr":"4214972246749820","authorId":4214972246749820,"authorIdStr":"4214972246749820","name":"股海蓝天","avatar":"https://static.tigerbbs.com/59436dc25a0c427f9500be9b0d23c3d6","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 3月是结直肠癌宣传月，而就在近期觅瑞结直肠癌产品已完成6000例临床入组，预计明年年中启动商业化。这种“成熟产品稳现金流+新品不断放量”的节奏，挺有看头的。</body></html>","htmlText":"<html><head></head><body><a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 3月是结直肠癌宣传月，而就在近期觅瑞结直肠癌产品已完成6000例临床入组，预计明年年中启动商业化。这种“成熟产品稳现金流+新品不断放量”的节奏，挺有看头的。</body></html>","text":"$MIRXES-B(02629)$ 3月是结直肠癌宣传月，而就在近期觅瑞结直肠癌产品已完成6000例临床入组，预计明年年中启动商业化。这种“成熟产品稳现金流+新品不断放量”的节奏，挺有看头的。","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/541793837334752","repostId":0,"isVote":1,"tweetType":1,"viewCount":601,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02629"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":160,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}